2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Amélio F Godoy-MatosCynthia Melissa ValerioWellington S Silva JúniorJoão Marcello de Araújo NetoMarcello Casaccia BertoluciPublished in: Diabetology & metabolic syndrome (2024)
, in which the combination of LSM and pharmacotherapy has not been shown to be effective in improving MASLD.